Search - tctmd.com

Displaying 1 - 20 of 103

Sort: Relevancy | Date

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Conference News ESC 2024

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

Yael L. Maxwell

September 04, 2024

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

News Daily News

Statin Use Has Plateaued in US Primary Prevention Patients

Michael O'Riordan

December 05, 2023

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Daily News

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

Yael L. Maxwell

October 12, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

Advertisement

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Aspirin Use for Primary Prevention Declining in US: NHANES

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Statins Effective For Primary Prevention in Old and Very Old

Statin Use Has Plateaued in US Primary Prevention Patients

Mortality Risk Varies Among Patients With Very High LDL Levels

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content